We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

103 hedge funds and large institutions have $435M invested in Assembly Biosciences in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 40 increasing their positions, 30 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

374% more call options, than puts

Call options by funds: $3.95M | Put options by funds: $833K

33% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 30

0.22% more ownership

Funds ownership: 6.99% → 7.21% (+0.22%)

3% less funds holding

Funds holding: 106 → 103 (-3)

10% less capital invested

Capital invested by funds: $483M → $435M (-$47.5M)

21% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 14

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
103
Holders Change
-3
Holders Change %
-2.83%
% of All Funds
2.23%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
11
Increased
40
Reduced
30
Closed
14
Calls
$3.95M
Puts
$833K
Net Calls
+$3.11M
Net Calls Change
+$3.21M

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$21.7M
2
SAM
Sectoral Asset Management
Quebec, Canada
+$11.8M
3
State Street
State Street
Massachusetts
+$8.03M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$5.1M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$3.51M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$26.4M
2
RI
RTW Investments
New York
-$15.5M
3
FCM
Farallon Capital Management
California
-$5.27M
4
BlackRock
BlackRock
New York
-$3.58M
5
3C
361 Capital
Colorado
-$2.59M
Name Holding Trade Value Shares
Change 		Change in
Stake
RI
101
RTW Investments
New York
– -$15.5M -57,220 Closed
3C
102
361 Capital
Colorado
– -$2.59M -9,547 Closed
Susquehanna International Group
103
Susquehanna International Group
Pennsylvania
– -$1.08M -4,279 Closed
SSA
104
Schonfeld Strategic Advisors
New York
– -$697K -2,567 Closed
Squarepoint
105
Squarepoint
New York
– -$593K -2,186 Closed
ARTA
106
A.R.T. Advisors
New York
– -$342K -1,260 Closed
HI
107
HBK Investments
Texas
– -$314K -1,158 Closed
HC
108
HNP Capital
New York
– -$271K -1,000 Closed
California Public Employees Retirement System
109
California Public Employees Retirement System
California
– -$218K -803 Closed
VOYA Investment Management
110
VOYA Investment Management
Georgia
– -$203K -748 Closed
Canada Life
111
Canada Life
Manitoba, Canada
– -$45K -172 Closed
BAMCO Inc
112
BAMCO Inc
New York
– -$43K -158 Closed
UBS Group
113
UBS Group
Switzerland
– -$37K -136 Closed
AG
114
Advisor Group
Arizona
– -$3K -10 Closed
GWS
115
Glassman Wealth Services
Virginia
– +$253 +1 New
QT
116
Quantamental Technologies
New York
– +$253 +1 New
1 2 3 4
5

ASMB Hedge Fund Activity: Q1 2019 in Review

103 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q1 2019, worth a combined $435M — down 9.8% from $483M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of ASMB and 11 opened new positions — a net loss of 3 holders — while 30 trimmed existing stakes and 40 added.

The largest buyer was Armistice Capital, adding an estimated $21.7M. The largest seller was EcoR1 Capital, cutting an estimated $26.4M.

  • 103 institutional investors held Assembly Biosciences (ASMB) as of Q1 2019, down from 106 in Q4 2018.
  • Funds reported $435M of Assembly Biosciences stock for Q1 2019, down 9.8% quarter-over-quarter.
  • 11 funds opened new Assembly Biosciences positions in Q1 2019 and 14 closed out, a net change of -3 holders.
  • The largest Assembly Biosciences buyer in Q1 2019 was Armistice Capital, an estimated $21.7M added.
  • The largest Assembly Biosciences seller in Q1 2019 was EcoR1 Capital, an estimated $26.4M sold.

Based on aggregated 13F filings for Q1 2019.